Insights

MGC Diagnostics Gears up for Busy Tradeshow Season

We have a busy tradeshow season ahead with over 14 tradeshows, regional state shows, practicums and educational gatherings, in this spring alone. We are seeing a growing desire for the in-person experience and a spike in attendance compared to the past two years.

MGC Diagnostics Wins Award for Best Designed Stand Incorporating Sustainable Goals at ERS Congress 2023

Exciting news from ERS 2023! MGC Diagnostics has been honord with the prestigious Best Designed Stand Incorporating Sustainable Goals at ERS 2023. Out of 130+ stands at ERS, we were chosen as the best representation of this award. Thank you ERS Congress for this incredible honor.

CAIRE Completes Acquisition of MGC Diagnostics Holdings, Inc.

CAIRE Inc., further expands clinical healthcare portfolio for patients facing pulmonary disease with the finalized acquisition of St. Paul, Minnesota-based MGC Diagnostics Holdings, Inc. 

MGC Diagnostics Ranked Among Fastest Growing Private Companies in the Twin Cities Metro Area by Minneapolis/St. Paul Business Journal

MGC Diagnostics is ranked one of the fastest growing private companies in the Twin Cities Metro Area of Minnesota by debuting on the Fast 50 list at No. 40 this year. 

Star Tribune Names MGC Diagnostics a 2021 Top Workplace

MGC Diagnostics has been named one of the Top Workplaces in Minnesota by the Star Tribune. Top Workplaces recognizes the most progressive companies in Minnesota based on employee opinions measuring engagement, organizational health and satisfaction.

Committed to Education, MGC Diagnostics Launches Book Giveaway

We are a leader in cardiopulmonary diagnostic systems and providing education opportunities to the respiratory community. As a way to show our appreciation to those who perform diagnostics testing, we gave away 20 copies of an invaluable book in July 2021.

Infection Control and Remote Patient Monitoring

As concern over the COVID-19 virus continues to grow and many pulmonary function labs remain open for testing, there is an increased scrutiny on patient safety and how patient health is monitored.

Global Distribution Agreement with Monitored Therapeutics, Inc. (MTI)

We are pleased to announce a global distribution agreement with Monitored Therapeutics, Inc. (MTI). Their portfolio includes the GoSpiro™ spirometer and MTI CarePortal™ cloud-based information platform. These in-home solutions help physicians and caregivers manage diseases via remote patient monitoring.

New Updates to Restarting Your Lab

With geographic areas beginning to re-open, this exclusive webinar will provide the most up-to-date information and guidance so that cardiorespiratory diagnostic labs can continue to make informed decisions regarding the process of resuming safe testing. Learn more in this free webinar.

Recording Now Available